Elevance Health, Inc.
ELV
$342.93
-$5.25-1.51%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.00% | 13.53% | 16.24% | 14.70% | 3.10% |
| Total Other Revenue | -1.21% | 6.55% | 3.85% | 15.55% | 24.21% |
| Total Revenue | 9.48% | 12.33% | 14.04% | 14.83% | 6.55% |
| Cost of Revenue | 13.63% | 15.75% | 20.06% | 15.60% | 6.91% |
| Gross Profit | -2.17% | 3.07% | -0.03% | 12.87% | 5.56% |
| SG&A Expenses | 2.34% | 9.86% | 4.09% | 18.05% | 20.88% |
| Depreciation & Amortization | -8.89% | 32.79% | -9.26% | 33.62% | -17.05% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.85% | 14.47% | 16.06% | 16.20% | 9.80% |
| Operating Income | -38.96% | -26.11% | -12.99% | -1.97% | -47.80% |
| Income Before Tax | -64.52% | 2.40% | -23.24% | -4.83% | -39.46% |
| Income Tax Expenses | -271.50% | -40.00% | -20.00% | -11.16% | 13.53% |
| Earnings from Continuing Operations | 32.20% | 17.76% | -24.21% | -2.89% | -50.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -80.00% | -75.00% | 0.00% | 66.67% | -80.00% |
| Net Income | 30.86% | 17.03% | -24.22% | -2.80% | -51.17% |
| EBIT | -38.96% | -26.11% | -12.99% | -1.97% | -47.80% |
| EBITDA | -29.10% | -20.80% | -10.35% | -0.59% | -41.55% |
| EPS Basic | 36.35% | 21.54% | -21.86% | -0.10% | -50.18% |
| Normalized Basic EPS | -54.78% | -30.01% | -13.95% | -2.08% | -56.90% |
| EPS Diluted | 36.35% | 22.02% | -21.62% | 0.21% | -50.17% |
| Normalized Diluted EPS | -54.78% | -29.77% | -13.73% | -1.80% | -56.90% |
| Average Basic Shares Outstanding | -4.02% | -3.71% | -3.01% | -2.71% | -1.99% |
| Average Diluted Shares Outstanding | -4.02% | -4.03% | -3.26% | -2.99% | -1.99% |
| Dividend Per Share | 4.91% | 4.91% | 4.91% | 4.91% | 10.14% |
| Payout Ratio | -0.23% | -0.14% | 0.34% | 0.05% | 1.21% |